Literature DB >> 17726064

Nucleocytoplasmic shuttling of persistently activated STAT3.

Andreas Herrmann1, Michael Vogt, Martin Mönnigmann, Thomas Clahsen, Ulrike Sommer, Serge Haan, Valeria Poli, Peter C Heinrich, Gerhard Müller-Newen.   

Abstract

Persistent activation of the transcription factor STAT3 has been detected in many types of cancer and plays an important role in tumor progression, immune evasion and metastasis. To analyze persistent STAT3 activation we coexpressed STAT3 with v-Src. We found that tyrosine phosphorylation of STAT3 by v-Src is independent of Janus kinases (Jaks), the canonical activators of STATs. The STAT3-induced feedback inhibitor, suppressor of cytokine signaling 3 (SOCS3), did not interfere with STAT3 activation by v-Src. However, the protein inhibitor of activated STAT3 (PIAS3) suppressed gene induction by persistently activated STAT3. We measured nucleocytoplasmic shuttling of STAT3 in single cells by bleaching the YFP moiety of double-labelled STAT3-CFP-YFP in the cytoplasm. Analysis of the subcellular distribution of CFP and YFP fluorescence over time by mathematical modeling and computational parameter estimation revealed that activated STAT3 shuttles more rapidly than non-activated STAT3. Inhibition of exportin-1-mediated nuclear export slowed down nucleocytoplasmic shuttling of v-Src-activated STAT3 resulting in reduced tyrosine phosphorylation, decreased induction of STAT3 target genes and increased apoptosis. We propose passage of persistently activated STAT3 through the nuclear pore complex as a new target for intervention in cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17726064     DOI: 10.1242/jcs.03482

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  43 in total

1.  Toxin-induced RhoA activity mediates CCL1-triggered signal transducers and activators of transcription protein signaling.

Authors:  Simone Reipschläger; Katharina Kubatzky; Sanaz Taromi; Meike Burger; Joachim Orth; Klaus Aktories; Gudula Schmidt
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

2.  Genetic screening for regulators of Prz1, a transcriptional factor acting downstream of calcineurin in fission yeast.

Authors:  Atsushi Koike; Toshiaki Kato; Reiko Sugiura; Yan Ma; Yuki Tabata; Koji Ohmoto; Susie O Sio; Takayoshi Kuno
Journal:  J Biol Chem       Date:  2012-04-11       Impact factor: 5.157

3.  Benzoxathiol derivative BOT-4-one suppresses L540 lymphoma cell survival and proliferation via inhibition of JAK3/STAT3 signaling.

Authors:  Byung Hak Kim; Yun Sook Min; Jung Sook Choi; Gyeong Hun Baeg; Young Soo Kim; Jong Wook Shin; Tae Yoon Kim; Sang Kyu Ye
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

4.  Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3.

Authors:  William B Grant
Journal:  Am J Pathol       Date:  2008-11       Impact factor: 4.307

Review 5.  Targeting signal transducer and activator of transcription signaling pathway in leukemias.

Authors:  Mustafa Benekli; Heinz Baumann; Meir Wetzler
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

6.  High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.

Authors:  Paul A Johnston; Malabika Sen; Yun Hua; Daniel Camarco; Tong Ying Shun; John S Lazo; Jennifer R Grandis
Journal:  Assay Drug Dev Technol       Date:  2013-10-15       Impact factor: 1.738

7.  Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development.

Authors:  Ralf Buettner; Renzo Corzano; Rumana Rashid; Jianping Lin; Maheswari Senthil; Michael Hedvat; Anne Schroeder; Allen Mao; Andreas Herrmann; John Yim; Hongzhi Li; Yate-Ching Yuan; Kenichi Yakushijin; Fumiko Yakushijin; Nagarajan Vaidehi; Roger Moore; Gabriel Gugiu; Terry D Lee; Richard Yip; Yuan Chen; Richard Jove; David Horne; John C Williams
Journal:  ACS Chem Biol       Date:  2011-02-16       Impact factor: 5.100

Review 8.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

9.  Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression.

Authors:  Emily C Brantley; L Burton Nabors; G Yancey Gillespie; Youn-Hee Choi; Cheryl Ann Palmer; Keith Harrison; Kevin Roarty; Etty N Benveniste
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

10.  Gender dependence for a subset of the low-abundance signaling proteome in human platelets.

Authors:  Ofer Eidelman; Catherine Jozwik; Wei Huang; Meera Srivastava; Stephen W Rothwell; David M Jacobowitz; Xiaoduo Ji; Xiuying Zhang; William Guggino; Jerry Wright; Jeffrey Kiefer; Cara Olsen; Nima Adimi; Gregory P Mueller; Harvey B Pollard
Journal:  Hum Genomics Proteomics       Date:  2010-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.